bioRxivImmunology
Regulation of specific cell clusters in TCR-T cells responding to differential expression of tumor PD-L1
D. Renpeng, S. Liu, H. Chen, B. Kang, R. Drmanac, Y. Gu, X. Dong, Q. Gao
Abstract
PD-L1 signaling is important in regulating T cell function and keeping balance of tumor microenvironment, but its role in modifying TCR-T cell cytotoxicity remains unknown. MART-1-specific TCR-T cells (TCR-TMART-1) were stimulated by MEL-526 tumor cells expressing different proportions of PD-L1 and used to perform cytotoxicity assays and single-cell RNA sequencing. Percentage changes of different specific cell clusters were analyzed. The percentage of cluster HLA-DR+CD38+CD8+ was upregulated after antigen stimulation and tumor PD-L1 modified TCR-T cell function through downregulating the percentages of clusters HLA-DR+CD28+CD8+ and HLA-DR+CD38+CD8+ which were higher in TCR-TMART-1 than in Tnull.
- organism: human
- assay: scRNA-seq
- research focus: cell type annotation
- research focus: differential expression
- approach: experimental assay
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Single-cell transcriptome analysis of the immunosuppressive effect of differential expression of tumor PD-L1 on responding TCR-T cells
- Dendritic cell PD-L2 restrains intratumoral CD8+ T cell immunity
Jinwoo Nah, Amanda Sun, … Chrysothemis C. Brown·bioRxiv·Sep 16, 2026
- PD-1 controls differentiation, survival, and TCR affinity evolution of stem-like CD8+ T cells
Jyh Liang Hor, Edward C. Schrom, … Ronald N. Germain·NaturePeer-reviewed·Nov 26, 2025
- PD-1-induced T cell exhaustion is controlled by a Drp1-dependent mechanism
L. Simula, V. Cancila, … S. Campello·bioRxiv·Jul 14, 2020
- PD-1 blockade-driven anti-tumor CD8+ T cell immunity requires XCR1+ dendritic cells
T. Mao, E. Song, A. Iwasaki·bioRxiv·Apr 28, 2020
- T cell co-stimulatory receptor CD28 is a primary target for PD-1-mediated inhibition
E. Hui, J. Cheung, … R. D. Vale·bioRxiv·Nov 9, 2016